The new company’s mission is to commercialise innovations from the University of Oslo, Oslo University Hospital and the southern health region of Norway, which includes the internationally renowned Ulleval, A-Hus and Radium Hospitals.
Read more about Inven2 in the article “Inven2 a new key player in the Oslo tech transfer and commercialization market”, Oslo Bio Update – ECCP 2010 special or in the article “Merger results in Norway’s largest TTO”, www.oslo.teknopol.no.